Your browser doesn't support javascript.
loading
The Pathological and Clinical Diversity of Acute Vascular Rejection in Kidney Transplantation.
Nankivell, Brian J; Shingde, Meena; P'Ng, Chow H.
Affiliation
  • Nankivell BJ; Department of Renal Medicine, Westmead Hospital, Sydney, NSW, Australia.
  • Shingde M; Department of Tissue Pathology and Diagnostic Oncology, Institute Of Clinical Pathology And Medical Research, Sydney, NSW, Australia.
  • P'Ng CH; Department of Tissue Pathology and Diagnostic Oncology, Institute Of Clinical Pathology And Medical Research, Sydney, NSW, Australia.
Transplantation ; 106(8): 1666-1676, 2022 08 01.
Article in En | MEDLINE | ID: mdl-35266923
ABSTRACT

BACKGROUND:

Vascular rejection (VR) is characterized by arteritis, steroid resistance, and increased graft loss but is poorly described using modern diagnostics.

METHODS:

We screened 3715 consecutive biopsies and retrospectively evaluated clinical and histological phenotypes of VR (n = 100) against rejection without arteritis (v0REJ, n = 540) and normal controls (n = 1108).

RESULTS:

Biopsy sample size affected the likelihood of arterial sampling, VR diagnosis, and final Banff v scores ( P < 0.001). Local v and cv scores were greatest in larger arteries (n = 258). VR comprised 15.6% of all rejection episodes, presented earlier (median 1.0 mo, interquartile range, 0.4-8 mo) with higher serum creatinine levels and inferior graft survival, versus v0REJ ( P < 0.001). Early VR (≤1 mo) was common (54%) and predicted by sensitization, delayed function, and prior corticosteroid use, with associated acute dysfunction and optimal therapeutic response, independent of Banff v score. Late VR followed under-immunosuppression in 71.4% (noncompliance 38.8%, iatrogenic 32.6%), and was associated with chronic interstitial fibrosis, incomplete renal functional recovery and persistent inflammation using sequential histopathology. The etiology was "pure" antibody-mediated VR (n = 21), mixed VR (n = 36), and "pure" T cell-mediated VR (n = 43). Isolated VR (n = 34, Banff i < 1 without tubulitis) comprised 24 T cell-mediated VR and 10 antibody-mediated VR, presenting with mild renal dysfunction, minimal Banff acute scores, and better graft survival compared with inflamed VR. Interstitial inflammation influenced acute renal dysfunction and early treatment response, whereas chronic tubulointerstitial damage determined long-term graft loss.

CONCLUSIONS:

VR is a heterogenous entity influenced by time-of-onset, pathophysiology, accompanying interstitial inflammation and fibrosis. Adequate histological sampling is essential for its accurate diagnostic classification and treatment.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arteritis / Kidney Transplantation / Kidney Diseases Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplantation Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arteritis / Kidney Transplantation / Kidney Diseases Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplantation Year: 2022 Document type: Article Affiliation country: